中文 | English
Return
Total: 6 , 1/1
Show Home Prev Next End page: GO
Author:(Dongxiang LIU)

2.Correlation between chemotherapeutic efficacy of paclitaxel and class Ⅲ β-tubulin protein expression in gastric carcinoma patients

Quanliang YANG ; Dongxiang ZENG ; Yongping LIU ; Yang LING ; Huawei JIANG ; Jian MA

Cancer Research and Clinic 2013;(2):94-95,99

3.A study on creating a promotion index system of medical quality in Grade Ⅲ hospitals in Beijing

Jun LI ; Baoli ZHOU ; Miaorong XIE ; Jiang QIAN ; Yabin YU ; Xiulan LI ; Dongxiang ZHENG ; Xiaoying LI ; Jinsheng ZHANG ; Ying WANG ; Kunling SHEN ; Shengcai HOU ; Xiangmei ZHAO ; Yutong ZHENG ; Yanghai CUI ; Jiang FENG ; Dongguo LIU ; Xiaosong LI ; Yong YAN

Chinese Journal of Hospital Administration 2011;27(4):254-257

4.Analysis of the protection of compensation rights for research participants

Aijuan SHENG ; Xiaoqi WANG ; Liyan SUN ; Dongxiang ZHENG ; Fang LIU

Chinese Medical Ethics 2024;37(5):507-513

5.Structural optimization and biological evaluation of 1,5-disubstituted pyrazole-3-carboxamines as potent inhibitors of human 5-lipoxygenase.

Yu ZHOU ; Jun LIU ; Mingyue ZHENG ; Shuli ZHENG ; Chunyi JIANG ; Xiaomei ZHOU ; Dong ZHANG ; Jihui ZHAO ; Deju YE ; Mingfang ZHENG ; Hualiang JIANG ; Dongxiang LIU ; Jian CHENG ; Hong LIU

Acta Pharmaceutica Sinica B 2016;6(1):32-45

6.Guidelines for Ethical Review Entrustment Contract of Life Science and Medical Research Involving Humans

Aijuan SHENG ; Meixia WANG ; Qiang LIU ; Zhongguang YU ; Hu CHEN ; Hui JIANG ; Jiyin ZHOU ; Xiaoqi WANG ; Haibin YU ; Mingjie ZI ; Yifeng JIANG ; Lei XU ; Tao SHI ; Guizhen SUN ; Dongxiang ZHENG

Chinese Medical Ethics 2023;36(5):492-498

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 6 , 1/1 Show Home Prev Next End page: GO